Healthcare & Life Sciences
R5 Pharmaceuticals Limited
United Kingdom
acquired
acquired
Stage
About
R5 Pharmaceuticals Limited was a contract research organisation (CRO) operating a sterile facility at BioCity in Nottingham that provided clinical trial services to drug manufacturers. The company was funded and supported by Catapult Ventures and was sold to Aesica in 2010.
Explore R5 Pharmaceuticals Limited's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.